About

Aditya Chaubey is a highly experienced and passionate professional with over a decade of research and development experience in biomaterials, tissue engineering, nanotechnology platforms, and cancer biology. He is deeply interested in leveraging technological advances to develop solutions to address global health problems and is committed to building and supporting the startup ecosystem. Aditya has a proven ability to drive strategic research and manage collaborations between clinicians, scientists, and business professionals. He excels at working on complex problems and is experienced in managing cross-functional teams, interacting with various stakeholders, mentoring and program building. He is also skilled at acquiring additional competencies as mandated by the changing nature of the biotech and life sciences industry. Aditya holds a PhD in Bioengineering from Clemson University and is currently pursuing an MBA at John Molson School of Business. He has done post-doctoral work at Cincinnati Children’s Hospital and most recently worked as Chief Scientific Officer at Mazumdar Shaw Center for Translational Research (MSCTR). He is currently working as an Intern - Scientific and Business Evaluations, Program Development & Partnerships at admare bioinnovations. Aditya's education history includes a Bachelor of Engineering in Metallurgical Engineering from NIT Rourkela, a Master of Science in Bioengineering, and a PhD in Bioengineering from Clemson University. He is also pursuing an MBA from Concordia University, which he expects to complete in December 2022. Aditya's tech stack includes Research Scientist, and he has 13.45 years of relevant experience. He has worked with several organizations, including amacathera, where he worked with the Principal Scientist towards developing target product profile (TPP) for assets, and John Molson Entrepreneurship Club, where he served as President. Aditya is a committed and driven professional who is passionate about making a difference in the field of affordable healthcare.